Author: Stephanie Figon, MS, RDN, LD

Founder of NutriScape.NET. As a dietitian since 1992, Steph Figon has had experiences in consulting, 15 years in clinical, and has operated a private practice nutrition counseling office for since 2011. Connect on Linkedin

HbA1c, insulin use predict real-world response to GLP-1 receptor agonists in type 2 diabetes

HbA1c, insulin use predict real-world response to GLP-1 receptor agonists in type 2 diabetes

A patient’s response to GLP-1 receptor agonist therapy in type 2 diabetes depends on several pretreatment characteristics, including baseline HbA1c, diabetes duration, age and use of insulin therapy, according to a real-world analysis published in Current Medical Research and Opinion.

Source: HbA1c, insulin use predict real-world response to GLP-1 receptor agonists in type 2 diabetes

CGM, machine learning reveal dysglycemia phenotypes in type 1 diabetes

CGM, machine learning reveal dysglycemia phenotypes in type 1 diabetes

Researchers have identified three distinct patterns of dysglycemia in adolescents with type 1 diabetes using a combination of blinded continuous glucose monitoring data and machine-learning techniques, offering clinicians an opportunity to better tailor therapy, according to findings published in Pediatric Diabetes. “The study demonstrates that among adolescents with type 1 diabetes and

Source: CGM, machine learning reveal dysglycemia phenotypes in type 1 diabetes

Early gestational diabetes diagnosis a shared risk factor for neonatal hypoglycemia, hyperbilirubinemia

Early gestational diabetes diagnosis a shared risk factor for neonatal hypoglycemia, hyperbilirubinemia

Children of mothers who meet the diagnostic criteria for gestational diabetes at an early gestational age are at higher risk for hypoglycemia and hyperbilirubinemia compared with those whose mothers are diagnosed later or not at all, according to findings published in Diabetic Medicine.

Source: Early gestational diabetes diagnosis a shared risk factor for neonatal hypoglycemia, hyperbilirubinemia